CROK (CROM19): A new high-prevalence antigen in the Cromer blood group system.

Asher, Orna; Finkel, Lilach; Yosephi, Lydia; Karamatic Crew, Vanja; Thornton, Nicole; Chezar, Judith; Akria, Luiza; Shinar, Eilat; Yahalom, Vered

Asher, Orna; Finkel, Lilach; Yosephi, Lydia; Karamatic Crew, Vanja; Thornton, Nicole; Chezar, Judith; Akria, Luiza; Shinar, Eilat; Yahalom, Vered.

Afiliação

Asher O; National Blood Group Reference Laboratory (NBGRL), Magen David Adom (MDA), National Blood Services, Ramat Gan, Israel.
Finkel L; National Blood Group Reference Laboratory (NBGRL), Magen David Adom (MDA), National Blood Services, Ramat Gan, Israel.
Yosephi L; National Blood Group Reference Laboratory (NBGRL), Magen David Adom (MDA), National Blood Services, Ramat Gan, Israel.
Karamatic Crew V; International Blood Group Reference Laboratory (IBGRL), NHSBT, Bristol, UK.
Thornton N; International Blood Group Reference Laboratory (IBGRL), NHSBT, Bristol, UK.
Chezar J; Blood Bank, The Western Galilee Hospital, Nahariya, Israel.
Akria L; Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel.
Shinar E; Blood Bank, The Western Galilee Hospital, Nahariya, Israel.
Yahalom V; Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel.

Transfusion ; 61(11): E85-E87, 2021 11.

Article em En | MEDLINE | ID: mdl-34558678

Assuntos

Antígenos de Grupos Sanguíneos; Antígenos CD55; Humanos; Prevalência

Palavras-chave

CROK negative; Cromer blood group system; antigen

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Grupos Sanguíneos Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transfusion Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google